NCT03707704 (MKraft_Erstr) is a clinical trial in Spinal Cord Injury, Acute, sponsored by Swiss Paraplegic Research, Nottwil.

Who is sponsoring NCT03707704?

NCT03707704 is sponsored by Swiss Paraplegic Research, Nottwil.

What condition does NCT03707704 study?

NCT03707704 studies Spinal Cord Injury, Acute.

Is NCT03707704 still recruiting?

NCT03707704 is currently completed. Last updated 13 January 2020.

Last reviewed 2020-01-13 · How we verify

NCT03707704: MKraft_Erstr

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Quality Control of a Strengthening Protocol in Subjects With Spinal Cord Injury

Completed Last updated 13 January 2020

What this trial tests

trial in Spinal Cord Injury, Acute in 20 participants. Completed in 30 November 2019.

Timeline

10 October 2018

Primary endpoint
30 June 2019

30 November 2019

Quick facts

Lead sponsor	Swiss Paraplegic Research, Nottwil
Status	Completed
Study type	OBSERVATIONAL
Enrollment	20
Start date	10 October 2018
Primary completion	30 June 2019
Estimated completion	30 November 2019
Sites	1 location across Switzerland

Conditions studied

Spinal Cord Injury, Acute — all drugs for Spinal Cord Injury, Acute →

Sponsor

Swiss Paraplegic Research, Nottwil — full company profile →

Who can join

18 and older, any sex, with Spinal Cord Injury, Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the master's thesis is to evaluate the clinic-internal strengthening concept of the Swiss Paraplegic Centre (SPZ). The SPZ is a rehabilitation clinic for spinal cord injured people. The strengthening concept has been routinely used since 2015. By default, the patients complete - depending on which training phase they are in - three to four strength training sessions per week. As part of the master's thesis, the development of maximum strength of patients with spinal cord injury (SCI) in primary rehabilitation will be studied. It is explicitly taken care of that the patients comply with the training requirements. Furthermore, factors which prevent a consistent buildup of strength - such as medical complications (pressure sores, pneumonia, urinary tract infections) - are systematically recorded. The findings should provide information on the effect and qualitative transfer of the existing strength concept in everyday clinical practice. The strength training performed is accompanied by the master student and documented in a standardized manner.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Spinal Cord Injury, Acute

Currently open trials in the same condition.

NCT06841770 — A Study to Evaluate the Safety of a Delivery Device for Administering LCTOPC1 in Participants With Spinal Cord Injury · Phase 1 · recruiting
NCT03965299 — Transcutaneous Tibial Nerve Stimulation in Acute Spinal Cord Injury · NA · recruiting

Other Swiss Paraplegic Research, Nottwil trials

Trials by the same sponsor.

NCT07456722 — Cardiac Morphology and Function in Individuals With Autonomic Dysreflexia · not yet recruiting
NCT06905470 — The Effects of Eccentric Compared to Standard Strength Training in Primary Spinal Cord Injury Rehabilitation · NA · not yet recruiting
NCT07165353 — Virtual Walking to Reduce Chronic Neuropathic Pain in Subjects With SCI · NA · recruiting
NCT06892080 — Urine Incontinence Occurrence and Sexual Hormones in Women With Chronic Spinal Cord Injury/Disease - a Pilot Study · recruiting
NCT06633588 — Decolonization Efficacy of Polyhexanide vs. Mupirocin · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03707704 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Swiss Paraplegic Research, Nottwil
Last refreshed: 13 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03707704.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing